» Articles » PMID: 10625024

The Effects of Vitamin D Insufficiency in Patients with Primary Hyperparathyroidism

Overview
Journal Am J Med
Specialty General Medicine
Date 2000 Jan 7
PMID 10625024
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Differences in the prevalence of vitamin D deficiency may explain why the frequency of symptoms in patients with primary hyperparathyroidism varies geographically. This study was performed to determine the prevalence in the United States of low 25-hydroxyvitamin D levels among patients with mild primary hyperparathyroidism, and the effect of 25-hydroxyvitamin D status on disease severity.

Methods: We studied 124 patients with mild primary hyperparathyroidism. Biochemical, bone mineral density, and bone histomorphometric indices were compared among patients whose serurm 25-hydroxyvitamin D levels were in the lowest and highest tertiles.

Results: Serum 25-hydroxyvitamin D levels (mean +/- SD) were in the low range of normal (21 +/- 11 ng/mL, normal 9 to 52 ng/mL). Levels were below normal in 9 (7%) patients, and below the level suggested for vitamin D "sufficiency" (20 ng/mL) in 66 (53%) patients. Those with lowest 25-hydroxyvitamin D levels had the highest parathyroid hormone levels (low tertile 158 + 66 pg/mL versus high tertile 103 +/- 2 pg/mL, P <0.0001). Other evidence of more active hyperparathyroidism in those with low 25-hydroxyvitamin D levels included higher serum alkaline phosphatase activity (114 +/- 48 U/L versus 91 +/-35 U/L, P <0.03), lower serum phosphorus levels (2.7 +/- 0.4 mg/dL, versus 3.0 +/- 0.4 mg/dL, P <0.01), and greater bone mineral density at the lumbar spine (0.94 +/- 0.03 g/cm2 versus 0.83 +/- 0.03 g/cm2, P <0.05) reflecting the protective effects of parathyroid hormone on cancellous bone. They also had enhanced bone turnover on bone biopsy. Despite the expected differences in vitamin D metabolism in African-Americans, results did not differ by race.

Conclusion: Vitamin D insufficiency or deficiency is common among patients with mild primary hyperparathyroidism. In these patients, the effects of primary hyperparathyroidism on biochemical, densitometric, and histomorphometric indices are more pronounced.

Citing Articles

Vitamin D Deficiency and the Presentation of Primary Hyperparathyroidism: A Mini Review.

Yedla N, Kim H, Sharma A, Wang X Int J Endocrinol. 2023; 2023:1169249.

PMID: 38115826 PMC: 10728357. DOI: 10.1155/2023/1169249.


Severe Hypercalcemia Due to Primary Hyperparathyroidism and Heterozygous Pathogenic Variant of CYP24A1.

Liu J, Angelos P, Barhoum M, Jain R JCEM Case Rep. 2023; 1(4):luad071.

PMID: 37909006 PMC: 10578407. DOI: 10.1210/jcemcr/luad071.


Influence of Vitamin D Deficiency on Cyclin D1-Induced Parathyroid Tumorigenesis.

Costa-Guda J, Corrado K, Bellizzi J, Saria E, Saucier K, Guemes-Aragon M Endocrinology. 2023; 164(11).

PMID: 37694586 PMC: 10517715. DOI: 10.1210/endocr/bqad137.


Clinicopathological Profile of Primary Hyperparathyroidism with Special Reference to Ki-67 Labelling Index.

Thanveer A, Kamalanathan S, Badhe B, Palui R, Rashmi K, Nadeem N Indian J Endocrinol Metab. 2023; 27(1):73-79.

PMID: 37215275 PMC: 10198192. DOI: 10.4103/ijem.ijem_208_22.


Analysis of the cause and management of persistent laboratory abnormalities occurring after the surgical treatment of primary hyperparathyroidism.

Lee J, Hong N, Kim J, Lee C, Kang S, Jeong J Ann Surg Treat Res. 2022; 103(1):12-18.

PMID: 35919112 PMC: 9300437. DOI: 10.4174/astr.2022.103.1.12.